Analgesics - United Kingdom | Statista Market Forecast

In the United Kingdom, the revenue in the Analgesics market is projected to reach US$953.20m in 2024.
It is anticipated that the market will experience an annual growth rate of 3.67% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, with US$7.24bn in 2024.
Considering the total population, the per capita revenue in the United Kingdom is estimated to be US$14.03 in 2024.
The United Kingdom is experiencing a growing trend in the analgesics market, with a rise in demand for natural and herbal remedies.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in United Kingdom has been experiencing steady growth in recent years.

Customer preferences: Consumers in the United Kingdom have shown a strong preference for over-the-counter analgesics, such as paracetamol and ibuprofen, due to their convenience and accessibility. These products are widely available in pharmacies, supermarkets, and online, making them easily accessible to a large number of consumers. Additionally, there is a growing trend towards natural and herbal remedies, with consumers seeking alternative options for pain relief.

Trends in the market: One of the key trends in the Analgesics market in United Kingdom is the increasing demand for topical analgesics. These products, such as creams, gels, and patches, provide localized pain relief and are often preferred by consumers for their ease of use and targeted application. This trend is driven by the growing aging population in the country, as well as the rising incidence of musculoskeletal conditions such as arthritis.Another trend in the market is the growing popularity of combination analgesics. These products combine different active ingredients, such as paracetamol and codeine, to provide more effective pain relief. Combination analgesics are particularly favored by consumers for the treatment of more severe pain, such as migraines or dental pain.

Local special circumstances: The National Health Service (NHS) in the United Kingdom plays a significant role in the Analgesics market. The NHS provides free healthcare to all residents, including prescription medications. This has led to a higher demand for prescription-strength analgesics, as patients can obtain them at no cost. However, there are also strict regulations in place to prevent misuse and overuse of these medications.

Underlying macroeconomic factors: The growing aging population in the United Kingdom is a key driver of the Analgesics market. As people age, they are more likely to experience chronic pain conditions, such as arthritis, which require long-term pain management. This has led to an increased demand for analgesics in the country.Additionally, the United Kingdom has a strong pharmaceutical industry, with several major companies manufacturing and distributing analgesic products. This has contributed to the availability and accessibility of analgesics in the market.In conclusion, the Analgesics market in United Kingdom is driven by customer preferences for over-the-counter products, such as paracetamol and ibuprofen, as well as a growing demand for topical and combination analgesics. The market is also influenced by the presence of the NHS, which provides free healthcare and prescription medications to residents. The growing aging population and the strong pharmaceutical industry in the country are underlying macroeconomic factors that contribute to the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.